“METASTATIC COLORECTAL CANCER MCRC WITH WILD-TYPE RAS: THE CONTINUATION OF ANTI-EGFR THERAPY WITH A CHANGE OF CHEMOTHERAPY AFTER DISEASE PROGRESSION”, Вопр. онкол., vol. 63, no. 3, pp. 456–460, Mar. 2017, doi: 10.37469/0507-3758-2017-63-3-456-460.